BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 7, 2007
View Archived Issues
AN-2690 study results encouraging
Read More
Case studies demonstrate activity of efalizumab in dermatologic diseases
Read More
Dimericine(TM) may ameliorate UVB-induced DNA damage
Read More
Snapshots from the 2007 Gastrointestinal Cancers Symposium: Part II
Read More
NF-kappaB inhibitors inhibit Abeta production in vitro: potential efficacy in AD
Read More
Target enrollment reached in phase III study of Bronchitol in bronchiectasis
Read More
South American studies planned for RPI-MN
Read More
Novel activation mechanism for the pain-sensing TRPA1 channel / News in Context
Read More
ZEN-012 active against a variety of tumors in vivo
Read More
Zonisamide effective against binge eating, although not well tolerated
Read More
Novel immunomodulatory agents disclosed in recent Kyorin and Novartis patents
Read More
Recent Isis and Louisiana State University patents report novel diagnostic agents
Read More
Recent patents impart new therapeutic agents for cancer
Read More
Biofusion launches Absynth Biologics
Read More
Novel prepandemic H5N1 vaccine filed in Japan
Read More
New phase II trial for prostaglandin derivative JB-991
Read More
New dosing recommendations for Rapamune in high immunologic risk patients
Read More
ProMetic BioSciences: pipeline status
Read More
CytoDyn acquires UTEK subsidiary
Read More
SciClone plans phase II study of SCV-07
Read More
Treatment begins in Cytori's adipose stem cell trial
Read More
Phase III Prochieve study for prevention of preterm birth fails to meet endpoints
Read More
Wyeth and Medivas collaborate to develop advanced hemophilia treatments
Read More
First pivotal obesity study of lorcaserin completes enrollment
Read More
Treatment completed in phase III trials of Miraxion in Huntington's disease
Read More
Cambrex shareholders approve sale of bio businesses to Lonza
Read More
Sequential schedule of docetaxel/gemcitabine shows promising activity in MBC
Read More
Meta-analysis finds trastuzumab to increase cardiotoxicity and brain metastasis
Read More